News

Just Short of Crazy on MSN1d
KOS AI Develops Non-Invasive Glucose Monitoring Technology, Stanford AI Expert Appointed CTO
KOS AI Argus KOS AI, a Silicon Valley health technology firm, has developed a non-invasive glucose monitoring device t ...
Endocrinology Advisor14d
FDA Clears Dexcom G7 15 Day for Continuous Glucose Monitoring
The Food and Drug Administration (FDA) has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for ...
Medscape4d
One Patient, Three Different CGMs, Three Glucose Profiles
may vary based on the continuous glucose monitoring (CGM) system used, resulting in differences that may affect the timing and choice of treatment decisions, such as insulin delivery or ...
DexCom Shares Rise in Premarket on FDA Clearance for Glucose Monitoring System
Shares traded 8.5% higher at $72.55. The company, which focuses on glucose biosensing--which measures glucose levels in wearers--said that the Food and Drug Administration has cleared the Dexcom G7 15 ...
Medical Xpress27d
Non-invasive blood glucose monitor uses pre-trained model to reduce calibration period from weeks to days
noninvasive glucose monitoring (NIGM) system that has a much shorter calibration period than systems now in use. In their study published in the journal Scientific Reports, the group developed ...
Yahoo Finance18d
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...